The complaint alleged the interim superintendent created a hostile work environment and undermined core financial controls.

In February 2026, West Pharmaceutical Services’ Board authorized a new share repurchase program of up to US$1.00 billion with no expiration date and declared a regular quarterly dividend of US$0.22 ...

Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the ...

The Tribunal initiated CIRP under Section 7 after finding undisputed debt exceeding ₹10.91 crore and admission of insolvency by the Corporate ...

The ITAT Kolkata held that revision under Section 263 was invalid where the Assessing Officer had already examined service tax liability and depreciation claims during assessment. The order was not ...